Researchers are testing type 2 diabetes drug Victoza as a possible treatment for non-alcoholic fatty liver disease, the most common form of liver disease in the United States, affecting about 20 percent of the population. The condition describes a wide range of conditions that are caused when fat builds up within the liver. Non-alcoholic steathohepatitis, or NASH, is the most serious form of the disease, and can lead to total liver failure requiring liver transplant. NASH is known as a silent killer because it does not present with many symptoms and those affected generally feel well. Risk factors include obesity, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.